Noncriteria antiphospholipid antibodies in antiphospholipid syndrome
International Journal of Laboratory Hematology · 2024-05 · 46 (S1) · 34-42
DOI: 10.1111/ijlh.14268 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 07.04.2024. Verfasst von Katrien M J Devreese. Beteiligte Einrichtung: Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Antibodies, Antiphospholipid. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombotic manifestations and/or obstetric complications in patients with persistently positive antiphospholipid antibodies (aPL). aPL are a heterogeneous group of autoantibodies, but only lupus anticoagulant, anticardiolipin (aCL), and antibeta2‐glycoprotein I antibodies (aβ2GPI) IgG or IgM are included as laboratory classification criteria. Seronegative APS patients are usually defined as patients with the clinical symptoms of APS but who test negative for aPL. The negativity to classic aPL criteria does not exclude the presence of other aPL. Several noncriteria aPL have been identified. Some noncriteria aPL are well studied, such as IgA aCL and aβ2GPI, the antiphosphatidylserine‐prothrombin (aPS/PT) antibodies, and the antibodies against the domain I of beta2‐glycoprotein I (aDI), both latter groups receiving more attention for their role in thrombotic events and pregnancy complications. Other noncriteria aPL that have been studied are antibodies against annexin V, prothrombin, phosphatidylethanolamine, phosphatidic acid, phosphatidylserine, phosphatidylinositol, vimentin‐cardiolipin complex, anti‐protein S/protein C. Measurement of some of these noncriteria aPL (aPS/PT, aDI) is useful in the laboratory work‐out of APS in specific situations. We have to differentiate between patients who are positive for noncriteria aPL only, and patients who have both criteria and noncriteria aPL to enable us to study their role in the diagnosis or risk stratification of APS. The research on noncriteria aPL is continually developing as the clinical relevance of these antibodies is not yet fully clarified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
ORCID-Profile: Katrien M J Devreese
Zitieren
APA
Devreese, K. M. J. (2024). Noncriteria antiphospholipid antibodies in antiphospholipid syndrome. International Journal of Laboratory Hematology, 46(S1), 34-42. https://doi.org/10.1111/ijlh.14268
Vancouver
Devreese KMJ. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome. International Journal of Laboratory Hematology. 2024;46(S1):34-42. doi:10.1111/ijlh.14268
BibTeX
@article{Devreese2024,
author = {Devreese, Katrien M J},
title = {Noncriteria antiphospholipid antibodies in antiphospholipid syndrome},
journal = {International Journal of Laboratory Hematology},
year = {2024},
volume = {46},
number = {S1},
pages = {34--42},
doi = {10.1111/ijlh.14268}
}
EUVIMED